(CIDRAP News) – Predicting that 44% of this year's supply of influenza vaccine won't be available until November and December, federal health officials are recommending that vaccine doses available in October be reserved for healthcare workers and people who have an increased risk of influenza complications.
(CIDRAP News) The federal government is considering buying influenza vaccine from a British company in an effort to remedy a possible shortage in the United States, the head of the Centers for Disease Control and Prevention (CDC) said today.
(CIDRAP News) The new recommendation to vaccinate children between 6 and 23 months old could have been lost in the hubbub of the influenza vaccine shortage this season. Yet authorities are terming this year's vaccination rates a success story.
(CIDRAP News) Influenza vaccine doses intended for those at highest risk for serious complications from the flu made it into the arms of the right people, the Centers for Disease Control and Prevention (CDC) in Atlanta said yesterday.
(CIDRAP News) A pair of new studies suggest that influenza vaccines based on adenoviruses, one of the causes of the common cold, may offer major advantages in the quest for protection from flu pandemics.
(CIDRAP News) Two studies reported in today's issue of the New England Journal of Medicine provide additional support for seasonal influenza immunization while shedding some light on questions about vaccination strategies and the efficacy of the vaccines.
(CIDRAP News) – California scientists report that their analysis of the medical literature has yielded data on more than 600 molecular components of influenza A viruses that trigger immune responses, findings they hope will spur the search for vaccines offering protection against multiple flu strains.
(CIDRAP News) – In an effort to stretch the nation's supply of vaccines for a potential influenza pandemic, federal health officials today announced contracts totaling $132.5 million to help three companies develop dose-sparing substances, or adjuvants, to be used with H5N1 flu vaccines.